Company profile

Ever Fortune.Ai, Co., Ltd.

Ever Fortune.Ai, Co., Ltd. has 10 AI-enabled medical devices on the FDA list. The first decision was on April 28, 2022 and the most recent on April 22, 2026 (EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100)). Its most common review panel is Radiology (10 devices).

10AI devices
2022First decision
2026Latest decision
1Specialties

Per year

2022: 22023: 22024: 32025: 12026: 2
20222023202420252026
Ever Fortune.Ai, Co., Ltd. AI devices per year: 2022 2, 2023 2, 2024 3, 2025 1, 2026 2

By specialty

  • Radiology10

Related guides

Timeline

  1. EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM (APPEN-CT-100) · Radiology · QAS
  2. Seg Pro V3 (RT-300) · Radiology · QKB
  3. EFAI Chestsuite XR Malpositioned ETT Assessment System (ETT-XR-100) · Radiology · QAS
  4. EFAI Neurosuite CT Midline Shift Assessment System (MLS-CT-100) · Radiology · QAS
  5. EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100) · Radiology · QIH
  6. EFAI CARDIOSUITE CTA ACUTE AORTIC SYNDROME ASSESSMENT SYSTEM · Radiology · QAS
  7. EFAI NeuroSuite CT ICH Assessment System · Radiology · QAS
  8. EFAI RTSUITE CT HCAP-Segmentation System · Radiology · QKB
  9. EFAI ChestSuite XR Pleural Effusion Assessment System · Radiology · QFM
  10. EFAI RTSuite CT HN-Segmentation System · Radiology · QKB